1,750
Participants
Start Date
July 19, 2018
Primary Completion Date
July 1, 2024
Study Completion Date
December 1, 2034
Durvalumab
controlled infusion via an infusion pump into a peripheral or central vein
Tremelimumab
controlled infusion via an infusion pump into a peripheral or central vein
RECRUITING
Aberdeen Royal Infirmary, Aberdeen
RECRUITING
Ysbyty Gwynedd, Bangor
RECRUITING
Royal Bournemouth Hospital, Bournemouth
RECRUITING
Bristol Haematology and Oncology Centre, Bristol
RECRUITING
Addenbrookes Hospital, Cambridge
RECRUITING
Velindre Cancer Centre, Cardiff
RECRUITING
Broomfield Hospital, Chelmsford
RECRUITING
Cheltenham General Hospital, Cheltenham
RECRUITING
Colchester General Hospital, Colchester
RECRUITING
University Hospital Coventry & Warwickshire, Coventry
RECRUITING
Western General Hospital, Edinburgh
RECRUITING
Beatson West of Scotland Cancer Centre, Glasgow
RECRUITING
Diana Princess of Wales Hospital, Grimsby
RECRUITING
Castle Hill Hospital, Hull
RECRUITING
Raigmore Hospital, Inverness
RECRUITING
St James University Hospital, Leeds
RECRUITING
Leicester Royal Infirmary, Leicester
RECRUITING
Clatterbridge Cancer Centre, Liverpool
RECRUITING
St Bartholomew's Hospital, London
RECRUITING
Mount Vernon Hospital, London
RECRUITING
Royal Free Hospital, London
RECRUITING
Guy's Hospital, London
RECRUITING
Royal Marsden Hospital, London
RECRUITING
Charing Cross Hospital, London
RECRUITING
The Christie, Manchester
RECRUITING
Nottingham University Hospital, Nottingham
RECRUITING
Churchill Hospital, Oxford
RECRUITING
Glan Clwyd Hospital, Rhyl
RECRUITING
Scunthorpe General Hospital, Scunthorpe
RECRUITING
Weston Park Hospital, Sheffield
RECRUITING
South Tyneside District Hospital, South Shields
RECRUITING
Southend University Hospital, Southend-on-Sea
RECRUITING
Sunderland Royal Hospital, Sunderland
RECRUITING
Royal Marsden Hospital, Sutton
RECRUITING
Torbay Hospital, Torquay
Collaborators (2)
AstraZeneca
INDUSTRY
Kidney Cancer UK
OTHER
Cancer Research UK
OTHER
University College, London
OTHER